 |
|
| Blog results | Results 1 - 10 of about 7,694 for psoriasis raptiva. (0.18 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | Advances in drug discovery - http://leaddiscovery.blogspot.com/ Raptiva Legal Center — Your center for raptiva legal information - http://www.raptivalegalcenter.com/ My Raptiva Lawsuit — Raptiva Lawsuit Information and Resources - http://myraptivalawsuit.com/ Psoriasis News - http://allstop.com/psoriasis-news/ I Hate Psoriasis! — Working towards clear, smooth skin. - http://www.ihatepsoriasis.com/ | |
| 29 May 2009 by admin On Raptiva? Then the clock's ticking. Your pharmacy will only give you a refill on your prescription till until Monday, June 8th. While we're happy that Genentech decided to voluntarily withdraw Raptiva from the market given the drug's ... lawyersandsettlements.com - http://www.lawyersandsettlements.com/blog/ |
| 4 Dec 2009 Genentech voluntarily withdraws psoriasis drug Raptiva®. On April 8, 2009, Genentech announced the voluntary withdrawal of Raptiva® (efalizumab) in the United States. The limited distribution specialty drug Is indicated for the ... Latest News from AFSPA - https://www.afspa.org/ |
| 28 Sep 2009 FDA Advises Public of Serious Adverse Event with Psoriasis Drug Raptiva. The FDA today issued a public health advisory concerning three confirmed, and one possible report of progressive multifocal leukoencephalopathy (PML), ... Sammie's Site - http://leathersammie.multiply.com/ |
| 4 Jun 2009 The Australian state-funded pharmaceutical benefits scheme (PBS) is to fund Abbott Laboratories' Humira (adalimumab) for severe chronic plaque psoriasis as an alternative treatment to other TNF-alfa inhibitors already funded for this ... Scrip News - Home - RSS - http://www.scripnews.com/scripnews/home/ |
| 9 Nov 2009 by Ed Wallis The FDA and pharmaceutical manufacturer Genentech have notified consumers and healthcare professionals of the phased withdrawal of the psoriasis medication Raptiva from the U.S. market over potential progressive multifocal ... Mid South Trial Lawyer - http://www.midsouthtriallawyer.com/ |
| 8 Apr 2009 by David Goguen Drugmaker Genentech is pulling the prescription psoriasis medication Raptiva (efalizumab) from the U.S. market, in what is being called a "voluntary, phased withdrawal of the product" by the U.S. Food and Drug Administration (FDA). ... Injured - http://blogs.findlaw.com/injured/ |
| 16 Oct 2008 Raptiva is given by injection once a week to treat moderate to severe plaque psoriasis in adults who are candidates for systemic (whole body) therapy or phototherapy (light therapy) to control their psoriasis. ... WebMD Health - http://www.webmd.com/ - References [ More results from WebMD Health ] |
| 14 Dec 2009 by admin Raptiva is a medication that is prescribed to treat psoriasis. It has been voluntarily withdrawn from the market because of links to this deadly infection. The Raptiva Recall was initiated by manufacturer on April 8, 2009, ... Raptiva Side Effects LawsuitRaptiva Lawsuit,... - http://www.raptivasideeffectslawsuit.com/ [ More results from Raptiva Side Effects LawsuitRaptiva Lawsuit,... ] |
| 9 Apr 2009 by timeinctemp The troubled psoriasis drug Raptiva is being withdrawn from the US market, California-based drug maker Genentech announced Wednesday. Health News - http://news.health.com/ [ More results from Health News ] |
| 14 Apr 2009 Find out why the psoriasis drug Raptiva has been taken off the market. RxList - News and Features - http://www.rxlist.com/script/main/hp.asp [ More results from RxList - News and Features ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
